Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

This publication has 38 references indexed in Scilit:

• Genomic signatures to guide the use of chemotherapeutics
  Nature Medicine, 2006
• A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
  Nature Genetics, 2006
• Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
  Proceedings of the National Academy of Sciences, 2006
• Chronic activation of protein kinase Bβ/Akt2 leads to multinucleation and cell fusion in human epithelial kidney cells: events associated with tumorigenesis
  Oncogene, 2005
• Molecular mechanisms of drug resistance
  The Journal of Pathology, 2005
• Parallel Chemical Genetic and Genome-Wide RNAi Screens Identify Cytokinesis Inhibitors and Targets
  PLoS Biology, 2004
• Biologically active sphingolipids in cancer pathogenesis and treatment
  Nature Reviews Cancer, 2004
• Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKCζ-Dependent Mechanism
  Molecular and Cellular Biology, 2003
• Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction
  Current Biology, 1999
• Programmed Cell Death Induced by Ceramide
  Science, 1993